Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal free Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115286578B enables metal-free production of high-purity pyrazole intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Metal-free synthesis of 5-trifluoromethyl triazole compounds enables scalable production with high purity and reduced manufacturing costs for pharmaceutical applications.
Patent CN118126005B enables metal-free synthesis of high-purity dihydrobenzofuran intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN116253692A enables metal-free triazine synthesis at room temperature, reducing manufacturing costs and ensuring supply chain continuity for pharmaceutical intermediates.
Discover how glucose-based synthesis of 3-trifluoromethyl-1,2,4-triazole eliminates anhydrous/oxygen-free requirements, cuts production costs, and ensures 99% purity for pharmaceutical intermediates.
Solve chiral drug synthesis challenges with metal-free catalysis. Achieve >99% ee, mild conditions, and scalable production for pharmaceutical intermediates. Reduce costs and supply chain risks.
Solve high-cost N-difluoromethylation challenges with this room-temperature, metal-free method. 90% yields, broad substrate tolerance, and no special equipment needed. Scale to 100 MT/yr.
Solve 5-trifluoromethyl imidazole synthesis challenges with our CDMO's scalable, high-yield process. Reduce costs by 30% and ensure supply chain stability for your API development.
Discover metal-free β-iodonitroalkene synthesis with 80%+ yields. Eliminate oxidant risks & simplify GMP production for API intermediates.
Solve metal contamination risks in 2-trifluoromethyl quinoline production. Our green, catalyst-free process ensures high purity and scalable manufacturing for drug development.
Eliminate heavy metal catalysts and nitrogen protection in pyrazole synthesis. Scale to 100MT/yr with 99% purity for drug development.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.
Solve 1,2,4-triazole synthesis challenges: 97% yield, no heavy metals, no anhydrous conditions. Reduce R&D costs and supply chain risks for API manufacturing.
Discover how metal-free diselenomaleimide synthesis at room temperature reduces production costs and supply chain risks for pharmaceutical intermediates. High-yield, scalable solution for R&D and procurement teams.
Discover a metal-free, low-cost synthesis method for 5-trifluoromethyl-1,2,4-triazole compounds. Eliminate heavy metal catalysts and reduce supply chain risks for your API manufacturing.
Discover metal-free pyrazole synthesis with 77-99% yield. Eliminate catalyst costs, simplify purification, and ensure GMP-compliant production for your drug development.
Solve supply chain risks with air-stable, metal-free synthesis of trifluoromethyl-1,2,4-triazine. 82%+ yields, no heavy metal catalysts. Scale from 100g to 100MT.
Solve high-cost synthesis challenges with this metal-free method for pharmaceutical intermediates. Eliminate heavy metal catalysts and reduce production risks. Contact for scalable manufacturing.
Eliminate explosive peroxides and heavy metals in 1,2,4-triazole synthesis. Our CDMO expertise scales this sulfur-promoted method for high-purity API intermediates with 99%+ purity.
Discover a catalyst-free pyrazole synthesis method with 47-92% yield. Reduce production costs and supply chain risks for pharmaceutical intermediates and agrochemicals.